The benzodiazepine receptor (BZR) is an important component of the g-aminobutyric acid (GABA A ) receptor complex, the activation of which enhances the actions of GABA A , an inhibitory neurotransmitter, on the Cl Ϫ conductance of the neuronal membrane. Three functionally distinct classes of compounds are known to interact with the BZR to modulate GABA interactions with its receptor and its associated Cl Ϫ channel function. These are agonists (e.g. diazepam), inverse agonists (e.g. methyl-6,7-dimethoxy-4-ethyl-b-carboline-3-carboxylate) and antagonists (e.g. flumazenil). Since the first description of the BZR, many investigators have attempted to identify the 'endogenous' BZR ligand. 1,4-Benzodiazepines, l-b-carboline-3-carboxylate, inosine and the diazepam binding peptide inhibitor have been proposed 1) to be natural BZR ligands, that is to say neurotransmitters or hormones synthesized in situ, released in response to specific physiological signals which then interact with the BZR. Up to the present time, flavonoids, 2,3) biflavonoids, 2, 3) terpenes 4, 5) and quinolines 4, 5) isolated from medicinal plants have been introduced as BZR agonists.
As part of our ongoing search for sedative agents from natural sources, [6] [7] [8] we evaluated the activity of the rhizomes of Cyperus rotundus L. (Cyperaceae), which have been used as an analgesic and as a sedative drug in Korean folk medicine. 9) Constituents of this plant have mainly been examined for terpenoids: besides a few saponins [10] [11] [12] and alkaloids, 13) more than 20 sesquiterpenes [14] [15] [16] [17] [18] [19] [20] [21] have been isolated. However, phytochemical research on this plant has not been thoroughly performed. Moreover, the effects of its constituents on GABAergic neurotransmission have not been reported yet.
Herein, we describe the isolation of some components, including new sesquiterpenes, from the active fraction of Cyperi Rhizoma and the agonistic property of a newly identified constituent from this plant on the rat cerebrocortical BZR. 22) Extraction and Isolation The dried and pulverized rhizomes of the plant (600 g) were extracted with n-hexane (2ϫ2 l) at 40°C to yield a hexane fraction (4.5 g). The residue was extracted with methanol and successively with ethylacetate to furnish the corresponding methanol fraction (94.5 g) and ethylacetate fraction (10.2 g). The active ethylacetate fraction gave at least five components by TLC (CH 2 Cl 2 and CHCl 3 /MeOH/H 2 O 10 : 1 : 0.1) using phosphomolybdic acid spray reagent (Aldrich Co.). This fraction was chromatographed on a silica gel column (230-400 mesh, Merck; 3ϫ50 cm) with the above solvents, affording four sesquiterpenes and one triterpene. Structural determinations of these compounds were based on comparison of GC/MS (HP5973 MSD system) and NMR (Varian XL-200, 200 MHz) spectra with published data, as follows (Rf value in CH 2 Cl 2 ): b-selinene (0.95), 11) isocurcumenol (0.77), 23) nootkatone (0.56), 24) aristolone (0.37) 25) Four sesquiterpenes, b b-selinene, isocurcumenol, nootkatone and aristolone and one triterpene, oleanolic acid were isolated from the ethylacetate fraction of the rhizomes of Cyperus rotundus and tested for their ability to modulate g g-aminobutyric acid (GABA A )-benzodiazepine receptor function by radioligand binding assays using rat cerebrocortical membranes. Among these compounds, only isocurcumenol, one of the newly identified constituents of this plant, was found to inhibit [ the first time from this plant.
MATERIALS AND METHODS

Materials and Animals
Receptor Binding Assay For the preparation of receptors, cerebral cortices of male Sprague-Dawley rats were removed immediately after rapid decapitation according to the American Association for Accreditation of Laboratory Animal Caretaker Guidelines. Tissues were disrupted in 50 volumes of 50 mM Tris-citrate buffer (pH 7
3 H]flunitrazepam (85.0 Ci/mmol) to the membranes were assayed using a filtration technique. Each assay comprised triplicate samples containing 0.16 mg protein suspended in 0.5 ml of 50 mM Tris-citrate buffer (pH 7.4) incubated for 60 min at 4°C in the presence of 1 nM radiolabeled ligands. Nonspecific binding was determined in the presence of 10 mM Ro15-1788 and represented about 10% of the total binding. The reactions were terminated by filtration through GF/B filters (Whatman) and three washes with 5 ml ice-cold buffer using a Harvesting apparatus (Brandel M-24R, Brandel Instruments, Gaithersberg, MD, U.S.A.). The radioactivity retained by the filters was measured in a liquid scintillation spectrometer (Wallac 1410, Turku, Finland) using 4 ml scintillation solution as a fluor. Protein was determined using a bichinchonic acid kit. In the competition assay for 3 H]Ro15-1788 binding is observed in the presence of GABA and NaCl, this will be interpreted as a 'positive GABA shift', suggesting that the BZR ligand in the extract has agonistic properties.
Statistical Analysis Data from the receptor binding assay were determined using non-linear regression analysis (Prism, Graphpad Software, San Diego, CA, U.S.A.). Intergroup comparisions of data were made by t-test and analysis of variance (ANOVA), followed by Neuman-Keuls multiple comparision analysis package (Systat Inc., Evanston, IL, U.S.A.).
RESULTS AND DISCUSSION
Activity-guided fractionation of the rhizomes of Cyperus rotundus and the isolation of five components (Fig. 1) from the active fraction were carried out and their abilities to modulate GABA A -benzodiazepine receptor function through BZR were examined by receptor binding assays.
The methanol fraction inhibited the specific binding of [ 3 H]Ro15-1788, a selective BZR antagonist, to rat cerebrocortical membranes, showing a diazepam equivalent (mg/g of weight) of 328.9Ϯ7.64 (Fig. 2) . The methanol fraction also inhibited the specific binding of (Fig. 2) . Based on these observations, the methanol fraction was further subfractioned with ethylacetate. The ethylacetate fraction exhibited about 5-fold higher diazepam equivalent value (1587.9Ϯ28.20) than the methanol fraction (Fig. 2) (Fig.  3) . These results suggested that the substance or substances acting as BZR agonist(s) may be contained in the ethylacetate fraction of C. rotundus.
Next, we isolated five components from the ethylacetate fraction and identified them as b-selinene, isocurcumenol, nootkatone, aristolone and oleanolic acid. Among them, isocurcumenol, nootkatone and aristolone were isolated for the first time from this plant. Except for isocurcumenol, the 
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Ϫ5 and 10 Ϫ4 M, respectively. Positive modulation of GABAergic neurotransmission by endogenous BZR agonists found in mammalian brain has been reported to be increased in the presence of GABA. 1) Therefore, the findings presented in this study suggest that isocurcumenol may allosterically modulate GABAergic neurotransmission via enhancement of interactions of GABA with its receptor in vivo.
Taken together, these observations may help to provide a pharmacological basis for the traditional applications of C. rotundus as a sedative. 
